Jared Matthews, an ambitious Cornell undergraduate, has achieved a rare feat: inventing a smart syringe that could revolutionize bioprinting and cell therapy. Developed in collaboration with Professor Lawrence Bonassar, the syringe measures the concentration and viability of cells in real time, helping surgeons and biomanufacturers produce higher-quality tissue implants.
The invention, born from Matthews’ sophomore research project, earned him a grant from Bill Nye’s 2019 fellowship. Bonassar praised the work, noting how rare it is for undergraduates to make such impactful breakthroughs, especially during the pandemic. The patent, issued in June, could have applications in hospitals and cell therapy worldwide.
After his success, Matthews moved on to develop next-generation medical devices and neural networks at GE HealthCare.


